These data suggest that the differences in SCNA frequency between TP53‐mutant and TP53 wild‐type tumours shown in Figure 4A are primarily driven by differences in SCNA frequency among tumours expressing higher levels of DDR1. The gene discussed is TP53; the disease is neoplasm.